China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Machine Learning-Based Study of Postoperative Nausea and Vomiting in Patients Undergo... Read More
China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical efficacy of fluoroscopic-assisted total Da Vinci robotic distal gastrectomy: p... Read More
China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Ultrasound-Guided Microwave Ablation Versus Radioiodine Therapy for Refractory or Recur... Read More
China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A clinical study of cerebral white matter high signaling and vascular-neurodegenerative... Read More
China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampici... Read More
China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Using Blood Tests to Detect Hidden Kidney Function Decline in Older Adults with Normal ... Read More
China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Analysis of Prognostic Risk Factors in Patients with Chronic Thromboembolic Pulmonary H... Read More
China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Value of Preprocedural Digital Subtraction Angiography Right Atrial Angiograph... Read More
China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction and Effect Evaluation of a Cardiovascular-Kidney-Metabolic (CKM) Syndrome ... Read More
China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An open-label, multicenter, phase I/II study evaluating the safety, tolerability, pharm... Read More